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Rab proteins are small GTPases highly related to the yeast Yptl and Sec4 proteins involved m secretion. The Rab proteins were found associated 
with membranes of different compartments along the secretory and endocyttc pathways. They share distinct C-terminal cysteme motifs required 
for membrane associatton. Unlike the other Rab protems. Rab8, Rabl 1 and Rab13 terminate with a C-terminal CaaX motif similar to those of 
RaslRho proteins This report demonstrates that Rab8 and Rab13 proteins are isoprenylated m vivo and geranylgeranylated in vitro. Rabll 
associates m vitro geranylgeranylpyrophosphate and farnesylpyrophosphate. Our study shows that the CaaX motif is required for isoprenylatton 
Rab small GTPase: Isoprenylation; C-termmal CaaX motif 
1. INTRODUCTION 
The small Ras-related GTP-binding proteins consti- 
tute a superfamily which can be grouped into four main 
branches according to their sequence similarities: Ras, 
Rho/Rat, Rab/Sec4/Ypt and Arf [l-6]. The Rab/Sec4/ 
Ypt family comprises more than thirty proteins which 
are involved in the regulation of vesicular traffic be- 
tween different membrane compartments [7]. Mutants 
studies in S. crrevisicle of Sec4 and Yptl proteins, pro- 
vided direct evidence for their involvement in vesicle 
transport [g-9]. The association of many Rab proteins 
with different subcellular compartments [ 1 O-l 31 and the 
in vivo and in vitro studies indicate a role for these 
proteins in the exocytic and endocytic pathways [7]. 
The mechanism responsible for the membrane associ- 
ation of these small GTPases is not clear. However, all 
members of the Ras superfamily (except Arf proteins) 
share one or two cysteines at their C-terminal end. Ras 
and RholRac proteins families present a C-terminal 
CaaX sequence (C, Cys; a, mostly aliphatic. and X, any 
amino acid [l]. This motif allows the protein to undergo 
a set of post-translational modifications necessary for 
their anchorage into the membranes which has been 
shown to be a critical step for p21Ras function [14]. The 
cysteine is first isoprenylated by the association of an 
unsaturated C,, or C,, lipidic chain; then the three ter- 
minal residues are removed and, in most cases, the cys- 
teine is carboxymethylated. The nature of the isoprenyl 
chain depends on the X amino acid: if it is a Met, a Ser, 
an Ala or a Cys, the protein appears to be farnesylated 
(C,s lipid) [15] by a farnesyl-transferase (FTase) [16]; 
When X is a Leu or a Phe, the protein would be ger- 
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anylgeranylated (Czo lipid) [15] by the geranylgeranyl- 
transferase 1 (GGTase I) [17]. 
Rab proteins present more heterogenic C-terminal 
motifs: CC (Rabl, Rab2. Rab9), CXC (Rab3, Rab4, 
Rab6) or CCXX (Rab5) [l]. So far, all prenylation stud- 
ies on these Rab proteins have led to the conclusion that 
they are geranylgeranylated [ 18-191. 
In contrast to the other members of the Rab/Sec4/Ypt 
family, three Rab proteins, more recently identified, 
present a CaaX motif at their C-terminus: Rab8 
(CVLL), Rab13 (CSLG) and Rabll ((C)CQNI) [4-51. 
In this paper we have investigated the post-translational 
modifications of these three human Rab proteins. We 
describe the isolation of rab8 and rabll cDNAs. The 
Rab8, Rabl 1 and Rab13 proteins were expressed in E. 
coli and showed to bind GTP. We present evidence that 
Rab8 and Rab13 incorporate in vivo a derivative of 
mevalonate and show that in vitro both proteins un- 
dergo a modification by 20 carbons geranylgeranyl 
groups. Rabl 1 seems to associate in vitro the two differ- 
ent isoprenoids. 
2. EXPERIMENTAL 
2.1 Screening of the lihrq 
2 x 10’ plaques of a pheochromocytoma cDNA 1gtlO library were 
screened with the oligonucleotide mixture sequence 5’- 
AC(A,C,G,T)AT(A.T)GG(A,C,G.T)AT(A.T)GATTTTAAG-3’ cor- 
responding to the TIGIDFK sequence of the effector domain of Sec4. 
Filters were prehybridized for 3 h and hybridized overnight at 42°C 
in 5 x SSPE. 5 x Denhart’s, 0.1% SDS, 100 &ml of somcated salmon 
sperm DNA m presence of 0.5 x IOb cpm/filter of [y-“P]dATP-ol- 
tgonucleottde. Thus filters were washed m 2 x SSC, 0.1% SDS 10 min 
at room temperature and 20 mm at 42°C. Phage DNA was prepared, 
cloned in bluescript plasmtd and sequenced usmg the T7 sequencing 
TM Kit (Pharmacta). We have screened the same pheochromocytoma 
library with an insert of 700 bp containing the whole coding region 
of rab6 cDNA. The probe was labeled with [a-“P]dCTP using the 
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random priming procedure. Hybridization was performed at 60°C 
and filters were washed in a solution contaming 1 x SSC, 0.1% SDS 
for 15 min at room temperature and 30 min at 68°C. 
2.2. Expression of the Rab protems m E. coli 
To express Rab protems m E co/i we performed site-directed mut- 
agenesis [3]. The following oligonucleotides: S-TCGAATTCCACA- 
TATGGCGAA-3’ for Rab8, 5’-GGTGTCCGCCATATGGCCAA- 
AG-3’ for Rab13. and 5’-GGCCGCGCATATGGGCACC-3’ for 
Rabll, were used to create NdeI sites, including the ATG imtiator 
codon, upstream from the codmg region. Mutations were confirmed 
by sequencing. The rab13 cDNA encoding Rab13,c.,, protein that 
lacks the CSLG C-terminal motif was generated by site-directed mut- 
agenesis using the 5’-CCAACAAGTGATCCCTGGGCT-3’ oligon- 
ucleotide. NdeI-BamHI inserts containing the complete coding re- 
gions were cloned into the PET-3c vector and expressed m the E coli 
BL21 (De3) pLysS strain [3]. Bacterial clones expressmg Rab proteins 
were identified by SDS-PAGE and GTP-bindmg overlays [20]. 
2.3. Anti-sera 
New Zealand rabbits were immunized against synthetic peptides 
covalently coupled to ovalbumin (Neosystem, Strasbourg, France) 
[20]. The peptide sequences were derived from the C-terminal regions 
of Rab13 NKPPSTDLKTC,,DKKNT, residues 1822197, and of 
Rab8 PQGSNQGVKITPDQQK, residues 1822197. Both anti-sera 
were specific for their respective antigene. They did not cross-react 
with other members of the Rab protein family [21] and Zahraoui et 
al., submitted). 
2.4. In vivo isoprenylation assay 
Coding regions of rab8 and rabl3 cDNAs were cloned m the 
pcEXV-3 vector [22]. Simian Cos-7 cells, in DMEM-10% foetal calf 
serum, were transfected with 10 pug DNA/6 cm diameter plate using 
a CaCl, precipitation method [23]. 48 h after transfection. cells were 
cultured in the presence of 50 ,uM of lovastatin (a generous gift from 
Dr. Slater, Merk Sharp and Dohme) for 1 h. The cells were then 
incubated in fresh medium supplemented with 50 PM lovastatin and 
lSO~Ci/ml of [‘Hlmevanololactone for 20 h. Cos-7 cells were lysed at 
4°C in TNE buffer (Tris-HCI. pH 8.0, 0.5 mM EDTA, 0.15 M NaCI. 
0.5% deoxycholate, 0.1% SDS. 0.5% nomdet-P40. lO~g/ml leupeptin, 
10 &ml aprotinin, 1 &ml pepstatin, 1 mM phenylmethylsulfonyl 
fluoride), and nuclei were removed by centrifugation for 10 mm at 
13,000 x g. Supernatants were precleared for 1 h using a rabbit preim- 
mune serum and protein A sepharose CL-4B beads (Sigma). Pre- 
cleared supernatants were incubated separately with anti-Rab8 or 
anti-Rab13 for 3.5 h at 4°C. Protein A sepharose beads were added 
for 2 h. Immune complexes were pelleted and washed two-fold with 
TNE containing 0.5 M NaCl and two-fold with TNE and resuspended 
in denaturation buffer, warmed and the supernatant electrophoresed. 
Gel was subjected to fluorographic treatment, 
2.5. In vitro isoprenylation assays 
In vitro isoprenylation assays were performed usmg 2pg (100 pmol) 
of purified H-Ras. 1OOpg (about 100 pmol) of extracts prepared from 
bacteria expressmg Rab protems (Rab8, Rabll, Rab13, Rabl3,,,,,) 
by Triton X-100 treatment and somcation as described by Wagner et 
al. [20]. Protems were separately Incubated with 50 pug of a brain 
cytosohc AS,, h,, fraction [19] in 50~1 of a solution containmg 25 mM 
Tris-HCI, pH 7.5. 10 mM DTT. 10 mM MgC&. 50 PM leupeptin. 0.1 
PM pepstatm and 10 PM ZnCIZ. I fltci of [ZH]GGPP or [‘HIFPP was 
added and reactions were carried out at 37°C for 1 h. Proteins were 
precipitated, electrophoresed and the gel were treated by Auorography 
as described elsewhere [ 191. 
3. RESULTS 
In order to isolate a mammalian homolog of the yeast 
Sec4 protein, we screened a pheochromocytoma cDNA 
library with a degenerated oligonucleotide correspond- 
ing to the sequence TIGIDFK, present in the effector 
region of Sec4. We isolated a cDNA clone encoding a 
protein that presents 5 1% amino acid identity with Sec4 
and 100% identity with the dog Rab8 protein [4]. A 
human rab8 cDNA (MEL gene cDNA) has been previ- 
ously reported [24]. The nucleotide sequence of the two 
rab8 cDNAs are exactly the same ~ including the non- 
coding regions - except for three deletions in the MEL 
cDNA sequence: Tj,,,, C,,, and G,,,, reflecting a proba- 
ble sequence error; consequently, the MEL product and 
our Rab8 amino acids sequences differ by a Glu”’ dele- 
tion and by five non-conservative amino acids substitu- 
tions at positions 177 to 18 1 (Fig. 1). 
Using the same strategy, we have recently identified 
a small GTP-binding protein, named Rab13, from a 
human epithelial cell cDNA library (Zahraoui et al., 
submitted). The Rab13 protein presents 92% amino 
acid identity with the partial sequence of the rat Rab13 
[5]. Rabl3 shared 64% and 56% identity with Rab8 and 
Sec4 proteins, respectively. As the chromosomic locali- 
sation of rub6 suggested the existence of a highly related 
gene [25], we screened the same pheochromocytoma 
library with a rab6 cDNA probe. We isolated a cDNA 
encoding a protein presenting 100% identity with the 
dog and human Rabl 1 proteins [4.26]. Rab8, Rabll 
and Rab13 proteins sequences share all the structural 
features of the Rab family but unlike other Rab pro- 
teins, they have a carboxy-terminal CaaX motif: CVLL 
for Rab8, CSLG for Rab13 and (CKQNI for Rabll. 
The rab8, rabll and rab13 cDNAs were subcloned 
in the PET-3c expression vector. Recombinant proteins 
cRab8 523 AAA AAA TTG GAA GGC AAC AGT CCC CAA GGG AGC AAC 558 
175 K K L E G N S P Q G S N 186 
hRab8 523 ?&A AAA TTG GAA GGC AAC AGC CCC CAG GGG AGC AAC 558 
175 K K L E G N S P Q G S N 186 
hRab8 (MEL) 523 AA?+ AAA TGG AAG GCA ACA GCC CCA GGG AGC AAC 555 
175 K K W K A T A P G S N 185 
Fig. 1 Partial sequence alignment of canine Rab8 (cRab8) [4], our human Rabd (hRab8) and hRabUMEL [24] showmg the nucleotide differences 
between cRab8 and our hRab8 on the one hand and hRab8/MEL on the other. The three nucleotide deletions in hRabS/MEL are underhned. The 
rab8 sequence is available from EMBL databases under the accessive number X56741 
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Fig. 2. GTP-binding of Rab8, Rabll and Rab13 proteins. A fraction 
of non-induced (NI) or isopropyl p-o-thiogalactopyranoside (IPTG) 
mduced (I) total bacterial lysates were separated by electrophoresis. 
transferred onto nitrocellulose membranes and incubated with [a- 
“P]GTP. Films were exposed for 15 min for Rab8 and Rab 11. or for 
2.5 days for Rab13. A basal expression of Rab proteins could be seen 
in non-induced tracks, especially for Rab 11. 
were produced in E. coli, separated on a poly- 
acrylamide-SDS gel, transferred on a nitrocellulose 
membrane and incubated with [ol-3’P]GTP. Fig. 2 shows 
that the three proteins bind radiolabelled GTP. 
To investigate whether the three Rab proteins were 
isoprenylated in vivo, we tested the incorporation of 
[3H]mevalonate derivatives (mevalonate is an isopre- 
noid precursor). For this purpose. simian Cos-7 cells 
were transfected with the pcEXV-3 vectors containing 
rab8 and rab13 cDNAs. The corresponding Rab pro- 
teins were transiently expressed in these cells. Trans- 
fected Cos cells were pretreated for 1 h with lovastatin. 
This drug, an inhibitor of isoprenoid metabolism, con- 
siderably inhibits mevalonic acid synthesis and conse- 
quently reduces the incorporation of endogenous 
isoprenyl groups. Cells were then incubated in fresh 
medium containing [3H]mevanololactone (MVA) and 
Rab proteins were isolated by immunoprecipitation 
with specific anti-Rab antibodies and SDS-PAGE. In- 
corporation of the 3H-lipid moieties into Rab8 and 
Rab13 was detected by fluorography. In both cases, the 
3H- labeled bands correspond to proteins exhibiting the 
expected molecular mass of Rab8 and Rab13 (Fig. 3). 
The low 3H-band corresponding to Rab13 probably 
reflects the feeble surexpression level of Rab 13. Indeed, 
when Cos-7 cells transiently expressing Rab13 were 
metabolically labeled with [35S]Met/Cys mixture (Trans- 
label, Amersham) and the protein was immunoprecipi- 
tated, we observed that Rab13 surexpression level is 
about 2-fold above control (data not shown). 
Having established that Rab8 and Rab13 proteins 
were isoprenylated in vivo, it was important to deter- 
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mine the nature of the incorporated isoprenoid group. 
We performed in vitro farnesylation and geranylger- 
anylation assays using [3H]farnesyl pyrophosphate 
(FPP) and [3H]geranylgeranyl pyrophosphate (GGPP). 
Rab8 and Rabl3 proteins were produced in E. coli and 
the extracts were incubated with a Azo_60 cytosolic frac- 
tion derived from a bovine brain, in presence of either 
[3H]FPP or [‘HIGGPP. The A20_60 fraction contains 
prenyl-transferases necessary for the reactions [19]. We 
found that Rab8 and Rab13 incorporated [3H]GGPP 
(Fig. 4). We did not observe a significant incorporation 
when the proteins were incubated with [‘HIFPP. No 
association of any labeled isoprenoid was seen in con- 
trol reactions performed either with only AZsbO fraction 
(Fig. 4) or with a lysate prepared from bacteria trans- 
formed with PET-3c vector alone (data not shown). As 
a positive control for farnesylation, Fig. 4 shows that 
purified H-Ras, as expected and in agreement with the 
published results [15], is only farnesylated. 
We next determined whether the CaaX motif is abso- 
lutely required for isoprenylation. We constructed a 
Rab13 mutant that lacks the CaaX C-terminal box, 
Rabl 3,CSLG. This truncated protein was produced in E. 
coli (Fig. 5A) and the bacterial extract was used in the 
in vitro isoprenylation assay in presence of [3H]GGPP. 
In contrast to the wild type Rab13, no incorporation of 
[3H]GGPP was detected by fluorography into the 
Rabl3,,s,o (Fig. 5B). This result indicates that the 
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Fig. 3. In vivo isoprenylation of Rab8 and Rabl3. Cos-7 cells were 
transfected wtth pcEXV/rab8 (Rab8). pcEXVlrabl3 (Rab13) or 
pcEXV alone (Control) and were labeled with [‘H]mevanololactone 
in presence of lovastatin. Cellular lysates were immunoprecipitated 
usmg anti-Rab8 (Rab8) or anti-Rab13 (Rabl3. Control) antibodies. 
Immunocomplexes were then electrophoresed on a SDS-poly- 
acrylamide gel and subjected to fluorography. Arrowheads indicate 
immunoprecipitated Rab8 and Rabl3 protems. Film was exposed 50 
days. 
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Fig. 4 In vitro prenylation of Rab8 and Rabl3. Purified H-Ras pro- 
tern.. Rabl3 or Rab8 bacterial extracts and no Rab protein (Control) 
were used for the assay in the presence of bovme brain cytosol fraction 
and I ,KI of [‘HIFPP (F) or of [ZH]GGPP (G). Protems were then 
precipitated and subjected to SDS-PAGE. Gel uas treated by fluoro- 
graphy and films were exposed for 3 (H-Ras) and IS days (RabX. 
Rabl3. Control) H-Ras does not incorporate [‘HIGGPP (data not 
shown). 
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We extended our analysis to Rabll protein which 
possesses. like RhoB (CCKVL) protein. a (C)CaaX 
motif at its C-terminal end (CCQNI) [l]. Previous re- 
sults have shown that Rabl 1 was isoprenylated in vivo 
but the nature of the incorporated isoprenoid was not 
determined [27]. We found that Rabll protein pro- 
duced in E. co/i, incubated with [-‘H]FPP or [3H]GGPP 
as described in Section 2. incorporated in vitro both 
isoprenoid lipids, indicating that Rabl 1 may be ger- 
anylgeranylated and farnesylated (Fig. 6). 
4. DISCUSSION 
Rab proteins have striking heterogenous C-terminal 
cystein motifs. In this study. we demonstrated that Rab 
proteins displaying, like p21 Ras. C-terminal CaaX 
boxes (Rab8, Rabl 1 and Rab13) are prenylated in vivo 
and in vitro. We also showed that the C-terminal CaaX 
motif is an essential structural component for signal 
prenylation since the truncated protein Rabl3,c,,, do 
not undergo geranylgeranylation. Similarly to Ras. the 
sequence of the post-translational modifications: iso- 
prenylation, proteolytic cleavage and probably carbox- 
ymethylation could occur sequentially on the Rab 
CaaX boxes. 
It appears that small GTPases presenting a Cas( M/S/ 
A/C) C-terminal motif are modified by FTase whereas 










Fig. 5. (A) Coomassie blue staining of bacterial extracts expressmg Rab13 and Rabl3,,,,,. IPTG Induced (I) or non-Induced (NI) bacteria were 
centrifuged and resuspended m 100 ~1 of water 12 ptl were denaturated and electrophoresed on a SDS-polyacrylamide gel. Arrowheads indicdte 
bands corresponding to Rabl3 and Rabl3,,,,,. Both proteins were recognized by the Rab13 antipeptide (data not shown). (B) Rabl3 or 
Rab13,c,,c, bacterial extracts were used for m vitro geranylgeranylation assay as Indicated m Fig 4. Protems were precipitated, electrophoresed 
and gel was subjected to Huorographic treatment Film was exposed for 7 days 
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Fig. 6. In vitro prenylation of Rabll. Rabll bacterial extract was 
incubated in the presence of bovine brain cytosol fraction and either 
1 ,&i of [‘HIFPP (F) or of [‘HIGGPP (G). Proteins were recipitated 
and separated by SDS-PAGE. Gels were treated by fluorography and 
films were exposed for 12 days. 
of GGTase I [15]. In both cases, in vivo and in vitro 
prenylation studies have suggested that the CaaX 
tetrapeptide was sufficient to ensure the association of 
the isoprenoid [28]. The rab proteins ending with CC or 
CXC motifs seem to be prenylated, probably like 
Rab3A on both cysteines [18], by another enzyme, the 
Rab GGTase also noted GGTase II [29]. 
The geranylgeranylation of Rab8, probably by 
GGTase I, is in concordance with previous data on 
other small GTPases that end with a CaaL box [15]. 
Previous results have shown that a Ras protein termi- 
nating with a CAIG tetrapeptide sequence instead of the 
CVLS box, was farnesylated [28]. Accordingly, and 
since the nature of the isoprenoid group is partly deter- 
mined by the last amino acid of the CaaX box 1151, 
Rab13 (CSLG) would be farnesylated. Our results 
showed only a geranylgeranylation of Rab 13. One pos- 
sible explanation is that amino acids situated within 
and/or upstream from the C-terminal motif could mod- 
ulate the prenylation signal. Rab13 could also be mod- 
ified by an enzyme different from GGTase I which 
would recognize, like GGTase II, long parts, or even the 
entire conformation of the substrate protein [30]. In- 
deed, in the case of some Rab proteins it has been shown 
that the C-terminal motif is essential but not sufficient 
for signal prenylation [27.30-311. RhoB (CCKVL) is the 
unique protein known to be geranylgeranylated and 
farnesylated [22]. Rabll, which presents a similar C- 
terminal (CCQNI) sequence motif, is also modified by 
both prenyl-transferases. However, compared to far- 
nesylation, geranylgeranylation is clearly predominant. 
Further studies would be required to determine whether 
Rabl 1 farnesylation occurs also in vivo. Rabl 1, like 
RhoB, could be prenylated by enzymes different from 
FTase and GGTase I. The finding that the RhoB mu- 
tant protein bearing the SCKVL motif at its carboxy- 
terminus was only farnesylated [22] is in contradiction 
with the expected isoprenylation of proteins presenting 
a CaaL box [15]. The CCaaX motif of Rabl 1 and 
RhoB, probably with amino acids sequences upstream 
from the C-terminal motif, might allow proteins to be 
modified by both types of prenyl-transferases, FTase 
and GGTase. 
Although the biological significance of these post- 
translational modifications are not fully understood, it 
has been demonstrated that the farnesylation of rho- 
dopsin kinase and geranylgeranylation of P-adrenergic 
receptor kinase are required for their membrane 
translocation and activity [32]. For Ras proteins, in 
addition to farnesylation, palmitolation of cysteines or 
the presence of a polybasic region upstream from the 
CaaX box is required for their plasma membrane local- 
ization [33]. In the case of Rab proteins, it has been 
shown that the hypervariable C-terminal region speci- 
fies their localization in appropriate secretory and endo- 
cytic compartments [34]. The presence of the prenyl 
group is required for both membrane attachment and 
function. The isoprenoid group might serve to anchor 
the Rab proteins in the lipid bilayer. It might also medi- 
ate the interaction with regulatory proteins necessary 
for the association/dissociation of Rab proteins from 
specific compartments. Proteins termed GDIs (for 
GDP dissocation inhibitor) that inhibit the release of 
GDP from Rab3A and Rabll have been identified. 
These GDIs have the capacity to dissociate the GDP- 
Rabprenylated form from membranes [35-361. It has 
been proposed that the complex Rab-GDI formed is 
then recognized by another membrane protein (Recep- 
tor, Guanine exchange factor) which would catalyze the 
specific insertion of Rab proteins to the membrane. It 
appears that Rab localization involves common post- 
translational modifications, specific sequence recogni- 
tion and probably interaction with yet unknown target 
proteins. 
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